Back to Browse Journals » International Journal of Nanomedicine » Volume 7

Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity

Authors Ding X, Sanchez DJ, Shahangian A, Al-Shyoukh I, Cheng G, Ho CM

Received 22 October 2011

Accepted for publication 3 March 2012

Published 10 May 2012 Volume 2012:7 Pages 2281—2292

DOI https://doi.org/10.2147/IJN.S27540

Review by Single-blind

Peer reviewer comments 4

Xianting Ding1, David Jesse Sanchez2,3, Arash Shahangian2, Ibrahim Al-Shyoukh1,4, Genhong Cheng2, Chih-Ming Ho1

1Department of Mechanical and Aerospace Engineering, UCLA, Los Angeles, CA, USA; 2Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA, USA; 3Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, CA, USA; 4Molecular and Medical Pharmacology Department, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA

Background: Infectious diseases cause many molecular assemblies and pathways within cellular signaling networks to function aberrantly. The most effective way to treat complex, diseased cellular networks is to apply multiple drugs that attack the problem from many fronts. However, determining the optimal combination of several drugs at specific dosages to reach an endpoint objective is a daunting task.
Methods: In this study, we applied an experimental feedback system control (FSC) method and rapidly identified optimal drug combinations that inhibit herpes simplex virus-1 infection, by only testing less than 0.1% of the total possible drug combinations.
Results: Using antiviral efficacy as the criterion, FSC quickly identified a highly efficacious drug cocktail. This cocktail contained high dose ribavirin. Ribavirin, while being an effective antiviral drug, often induces toxic side effects that are not desirable in a therapeutic drug combination. To screen for less toxic drug combinations, we applied a second FSC search in cascade and used both high antiviral efficacy and low toxicity as criteria. Surprisingly, the new drug combination eliminated the need for ribavirin, but still blocked viral infection in nearly 100% of cases.
Conclusion: This cascade search provides a versatile platform for rapid discovery of new drug combinations that satisfy multiple criteria.

Keywords: drug combination, HSV-1, combinatorial drug optimization, feedback system control, FSC, drug screening

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Connectomics in psychiatric research: advances and applications

Cao M, Wang Z, He Y

Neuropsychiatric Disease and Treatment 2015, 11:2801-2810

Published Date: 29 October 2015

Differential effects of dopamine-directed treatments on cognition

Ashby FG, Valentin VV, von Meer SS

Neuropsychiatric Disease and Treatment 2015, 11:1859-1875

Published Date: 29 July 2015

Reduced brain resting-state network specificity in infants compared with adults

Wylie KP, Rojas DC, Ross RG, Hunter SK, Maharajh K, Cornier M-A, Tregellas JR

Neuropsychiatric Disease and Treatment 2014, 10:1349-1359

Published Date: 21 July 2014

Erratum

Iancu C, Mocan L

International Journal of Nanomedicine 2011, 6:2543-2544

Published Date: 21 October 2011

Molecular network topology and reliability for multipurpose diagnosis

Jalil MA, Moongfangklang N, Innate K, Mitatha S, Ali J, Yupapin PP

International Journal of Nanomedicine 2011, 6:2385-2392

Published Date: 19 October 2011

Multi-access drug delivery network and stability

Mitatha S, Moongfangklang N, Jalil MA, Suwanpayak N, Ali J, Yupapin PP

International Journal of Nanomedicine 2011, 6:1757-1764

Published Date: 23 August 2011

Optimizing particle size for targeting diseased microvasculature: from experiments to artificial neural networks

Boso DP, Lee S, Ferrari M, Schrefler BA, Decuzzi P

International Journal of Nanomedicine 2011, 6:1517-1526

Published Date: 19 July 2011

Proposal for Alzheimer’s diagnosis using molecular buffer and bus network

Mitatha S, Moongfangklang N, Jalil MA, Suwanpayak N, Saktioto T, Ali J, Yupapin PP

International Journal of Nanomedicine 2011, 6:1209-1216

Published Date: 14 June 2011

Preparation of silver nanoparticles in virgin coconut oil using laser ablation

Reza Zamiri,B Z Azmi. Amir Reza Sadrolhosseini, et al 

International Journal of Nanomedicine 2011, 6:71-75

Published Date: 7 January 2011